Clinical Trial Update: Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating XC243 for exacerbation of chronic cystitis is listed; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis

Drugs mentioned

• XC243

Snippet

Sponsor: PHARMENTERPRISES LLC | Conditions: Cystitis | Phase 2 | Status: NOT_YET_RECRUITING